Cancer BiologybioRxivPreprint
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
F. Maerkl, C. Schultheiss, M. Ali…·M. Binder
This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.
DOI 10.1101/2023.09.29.560075